{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:20:13Z","timestamp":1790198413649,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074193"],"award-info":[{"award-number":["82074193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cExtensive Collection & Harmony Integration\u201d Projects of Peking University Third Hospital","award":["2404-01-01"],"award-info":[{"award-number":["2404-01-01"]}]},{"name":"Youth Talent Support Program of the China Association of Chinese Medicine","award":["2024-QNRC2-B13"],"award-info":[{"award-number":["2024-QNRC2-B13"]}]},{"name":"Clinical Key Project of Peking University Third Hospital","award":["BYSY2023049"],"award-info":[{"award-number":["BYSY2023049"]}]},{"name":"Special Fund of the Beijing Clinical Key Specialty Construction Program, P. R. China","award":["BJZKBC0011"],"award-info":[{"award-number":["BJZKBC0011"]}]},{"name":"Beijing Natural Science Foundation","award":["7252271"],"award-info":[{"award-number":["7252271"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Bushen Huatan Huoxue Formula (BHHF), a traditional Chinese medicine decoction, demonstrates potential in treating polycystic ovary syndrome (PCOS), a prevalent endocrine disorder in women of reproductive age that is closely associated with obesity and metabolic dysregulation. However, the underlying molecular mechanisms of BHHF\u2019s action remain unclear. This study aimed to evaluate the therapeutic efficacy of BHHF in obesity-associated PCOS and investigate its regulatory mechanisms related to metabolic homeostasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In vivo, three-week-old female Sprague Dawley rats were divided into seven groups: control, dehydroepiandrosterone (DHEA), high-fat diet (HFD), model (HFD\u2009+\u2009DHEA), low-dose BHHF, high-dose BHHF, and metformin. The PCOS model was induced by DHEA injection. BHHF was administered by gastric gavage for four weeks. Body weight, fat volume, glucose tolerance, and insulin sensitivity were measured. Ovarian histology, hormone analysis, RNA extraction, quantitative real-time PCR, protein extraction, western blotting, and proteomics studies were also conducted. In vitro, 3T3-L1 cells were used to assess lipid accumulation, mitochondrial function, and the effects of BHHF-containing serum.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>BHHF restored reproductive cyclicity and polycystic ovarian morphology, reduced testosterone and anti-M\u00fcllerian hormone levels, and increased estradiol levels. It also alleviated weight gain, reduced fat volume, improved glucose tolerance, and enhanced insulin sensitivity. Proteomics analysis revealed that BHHF activated the AMPK signaling pathway and promoted white adipose tissue browning. In vitro, BHHF-containing serum suppressed lipid accumulation and enhanced mitochondrial oxygen consumption. The bioactive components of BHHF\u2013Bushen (BS), Huatan (HT), and Huoxue (HX) \u2013exhibited specific functions. BS improved estrous cyclicity and ovarian morphology; HT regulated glucose and lipid metabolism and promoted adipose browning; and HX modulated mitochondrial bioenergetics and redox homeostasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>BHHF exerts multi-targeted therapeutic effects on obesity-associated PCOS by regulating metabolic-reproductive crosstalk. Its components act synergistically, offering a novel therapeutic strategy for PCOS treatment. Future research should focus on identifying core active compounds and optimizing treatment according to individual PCOS phenotypes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13020-025-01165-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:18:24Z","timestamp":1751368704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanistic insights into the Bushen Huatan Huoxue Formula and its components in ameliorating obesity-associated polycystic ovary syndrome"],"prefix":"10.1186","volume":"20","author":[{"given":"Yu-Xin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Qi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Yan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Wen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-4579","authenticated-orcid":false,"given":"Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1165_CR1","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108:2447\u201369. https:\/\/doi.org\/10.1210\/clinem\/dgad463.","journal-title":"J Clin Endocrinol Metab"},{"key":"1165_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024;10:27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3.","journal-title":"Nat Rev Dis Primers"},{"key":"1165_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7090089","author":"V Rodriguez Paris","year":"2019","unstructured":"Rodriguez Paris V, Bertoldo MJ. The mechanism of androgen actions in PCOS etiology. Med Sci. 2019. https:\/\/doi.org\/10.3390\/medsci7090089.","journal-title":"Med Sci"},{"key":"1165_CR4","doi-asserted-by":"publisher","first-page":"9240569","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:9240569. https:\/\/doi.org\/10.1155\/2022\/9240569.","journal-title":"J Healthc Eng"},{"key":"1165_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104535","volume":"90","author":"AL Barbotin","year":"2023","unstructured":"Barbotin AL, Mimouni NEH, Kuchcinski G, Lopes R, Viard R, Rasika S, et al. Hypothalamic neuroglial plasticity is regulated by anti-Mullerian hormone and disrupted in polycystic ovary syndrome. EBioMedicine. 2023;90: 104535. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104535.","journal-title":"EBioMedicine"},{"key":"1165_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218211","author":"RPM Steegers-Theunissen","year":"2020","unstructured":"Steegers-Theunissen RPM, Wiegel RE, Jansen PW, Laven JSE, Sinclair KD. Polycystic ovary syndrome: a brain disorder characterized by eating problems originating during puberty and adolescence. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21218211.","journal-title":"Int J Mol Sci"},{"key":"1165_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabet Endocrinol. 2022;10:668\u201380. https:\/\/doi.org\/10.1016\/S2213-8587(22)00163-2.","journal-title":"Lancet Diabet Endocrinol"},{"key":"1165_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1139\/cjpp-2023-0169","volume":"101","author":"K Olaniyi","year":"2023","unstructured":"Olaniyi K, Areloegbe S. Alleviation of adipose-hepatic glycolipid dysregulation by acetate in experimental PCOS model is associated with NF-kappaB\/NLRP3 repression. Can J Physiol Pharmacol. 2023;101:630\u201341. https:\/\/doi.org\/10.1139\/cjpp-2023-0169.","journal-title":"Can J Physiol Pharmacol"},{"key":"1165_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020583","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23020583.","journal-title":"Int J Mol Sci"},{"key":"1165_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020546","author":"TM Barber","year":"2021","unstructured":"Barber TM, Kyrou I, Randeva HS, Weickert MO. Mechanisms of insulin resistance at the crossroad of obesity with associated metabolic abnormalities and cognitive dysfunction. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22020546.","journal-title":"Int J Mol Sci"},{"key":"1165_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jare.2023.11.033","volume":"65","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Jin Y, Wu T, Wang Y, Dong Y, Chen P, et al. New insights on mitochondrial heteroplasmy observed in ovarian diseases. J Adv Res. 2024;65:211\u201326. https:\/\/doi.org\/10.1016\/j.jare.2023.11.033.","journal-title":"J Adv Res"},{"key":"1165_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010243","author":"A Lerner","year":"2020","unstructured":"Lerner A, Kewada D, Ahmed A, Hardy K, Christian M, Franks S. Androgen reduces mitochondrial respiration in mouse brown adipocytes: a model for disordered energy balance in polycystic ovary syndrome. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010243.","journal-title":"Int J Mol Sci"},{"key":"1165_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4239\/wjd.v13.i1.5","volume":"13","author":"S Livadas","year":"2022","unstructured":"Livadas S, Anagnostis P, Bosdou JK, Bantouna D, Paparodis R. Polycystic ovary syndrome and type 2 diabetes mellitus: a state-of-the-art review. World J Diabet. 2022;13:5\u201326. https:\/\/doi.org\/10.4239\/wjd.v13.i1.5.","journal-title":"World J Diabet"},{"key":"1165_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.888194","volume":"9","author":"Y Chen","year":"2022","unstructured":"Chen Y, Ma L, Ge Z, Pan Y, Xie L. Key genes associated with non-alcoholic fatty liver disease and polycystic ovary syndrome. Front Mol Biosci. 2022;9: 888194. https:\/\/doi.org\/10.3389\/fmolb.2022.888194.","journal-title":"Front Mol Biosci"},{"key":"1165_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12916-023-02775-0","volume":"21","author":"D Liu","year":"2023","unstructured":"Liu D, Gao X, Pan XF, Zhou T, Zhu C, Li F, et al. The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. BMC Med. 2023;21:62. https:\/\/doi.org\/10.1186\/s12916-023-02775-0.","journal-title":"BMC Med"},{"key":"1165_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41574-022-00636-z","volume":"18","author":"AE Joham","year":"2022","unstructured":"Joham AE, Teede HJ. PCOS - a metabolic condition with health impacts on women and men. Nat Rev Endocrinol. 2022;18:197\u20138. https:\/\/doi.org\/10.1038\/s41574-022-00636-z.","journal-title":"Nat Rev Endocrinol"},{"key":"1165_CR17","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1111\/dom.15867","volume":"26","author":"G Whelehan","year":"2024","unstructured":"Whelehan G, Bello O, Hakim O, Ladwa M, Umpleby AM, Amiel SA, et al. Ethnic differences in the relationship between ectopic fat deposition and insulin sensitivity in black African and White European men across a spectrum of glucose tolerance. Diabet Obes Metab. 2024;26:5211\u201321. https:\/\/doi.org\/10.1111\/dom.15867.","journal-title":"Diabet Obes Metab"},{"key":"1165_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/OGX.0000000000000661","volume":"74","author":"KM Brennan","year":"2019","unstructured":"Brennan KM, Kroener LL, Chazenbalk GD, Dumesic DA. Polycystic ovary syndrome: impact of lipotoxicity on metabolic and reproductive health. Obstet Gynecol Surv. 2019;74:223\u201331. https:\/\/doi.org\/10.1097\/OGX.0000000000000661.","journal-title":"Obstet Gynecol Surv"},{"key":"1165_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12020-024-03702-w","volume":"85","author":"D Mladenovic","year":"2024","unstructured":"Mladenovic D, Veskovic M, Sutulovic N, Hrncic D, Stanojlovic O, Radic L, et al. Adipose-derived extracellular vesicles - a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome. Endocrine. 2024;85:18\u201334. https:\/\/doi.org\/10.1007\/s12020-024-03702-w.","journal-title":"Endocrine"},{"key":"1165_CR20","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE. Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab. 2020;105:e2695\u2013709. https:\/\/doi.org\/10.1210\/clinem\/dgaa285.","journal-title":"J Clin Endocrinol Metab"},{"key":"1165_CR21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.17219\/acem\/151695","volume":"31","author":"GS Papaetis","year":"2022","unstructured":"Papaetis GS, Kyriacou A. GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: current research and future horizons. Adv Clin Exp Med. 2022;31:1265\u201374. https:\/\/doi.org\/10.17219\/acem\/151695.","journal-title":"Adv Clin Exp Med"},{"key":"1165_CR22","doi-asserted-by":"publisher","first-page":"e817","DOI":"10.1210\/clinem\/dgad465","volume":"109","author":"J Melin","year":"2024","unstructured":"Melin J, Forslund M, Alesi S, Piltonen T, Romualdi D, Spritzer PM, et al. Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2024;109:e817\u201336. https:\/\/doi.org\/10.1210\/clinem\/dgad465.","journal-title":"J Clin Endocrinol Metab"},{"key":"1165_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053.pub6","author":"LC Morley","year":"2017","unstructured":"Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017. https:\/\/doi.org\/10.1002\/14651858.CD003053.pub6.","journal-title":"Cochrane Database Syst Rev"},{"key":"1165_CR24","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/clinem\/dgad762","volume":"109","author":"V Fitz","year":"2024","unstructured":"Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A, et al. Inositol for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 update of the international evidence-based PCOS guidelines. J Clin Endocrinol Metab. 2024;109:1630\u201355. https:\/\/doi.org\/10.1210\/clinem\/dgad762.","journal-title":"J Clin Endocrinol Metab"},{"key":"1165_CR25","doi-asserted-by":"publisher","first-page":"263349412090870","DOI":"10.1177\/2633494120908709","volume":"14","author":"D Romualdi","year":"2020","unstructured":"Romualdi D, Versace V, Lanzone A. What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment. Ther Adv Reprod Health. 2020;14:2633494120908709. https:\/\/doi.org\/10.1177\/2633494120908709.","journal-title":"Ther Adv Reprod Health"},{"key":"1165_CR26","doi-asserted-by":"publisher","first-page":"4892215","DOI":"10.1155\/2022\/4892215","volume":"2022","author":"J Zhang","year":"2022","unstructured":"Zhang J, Xin X, Zhang H, Zhu Y, Ye Y, Li D. The efficacy of chinese herbal medicine in animal models of polycystic ovary syndrome: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2022;2022:4892215. https:\/\/doi.org\/10.1155\/2022\/4892215.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1165_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.874914","volume":"13","author":"LH Zeng","year":"2022","unstructured":"Zeng LH, Rana S, Hussain L, Asif M, Mehmood MH, Imran I, et al. Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies. Front Pharmacol. 2022;13: 874914. https:\/\/doi.org\/10.3389\/fphar.2022.874914.","journal-title":"Front Pharmacol"},{"key":"1165_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12906-023-04280-6","volume":"23","author":"HR Guan","year":"2023","unstructured":"Guan HR, Li B, Zhang ZH, Wu HS, He XL, Dong YJ, et al. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome. BMC Complement Med Ther. 2023;23:458. https:\/\/doi.org\/10.1186\/s12906-023-04280-6.","journal-title":"BMC Complement Med Ther"},{"key":"1165_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153654","volume":"91","author":"Z Wang","year":"2021","unstructured":"Wang Z, Nie K, Su H, Tang Y, Wang H, Xu X, et al. Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome. Phytomedicine. 2021;91: 153654. https:\/\/doi.org\/10.1016\/j.phymed.2021.153654.","journal-title":"Phytomedicine"},{"key":"1165_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103665","author":"M Rondanelli","year":"2021","unstructured":"Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T, et al. Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome: a one-group pretest-post-test explanatory study. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13103665.","journal-title":"Nutrients"},{"key":"1165_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1160\/pamj.2023.44.134.32404","volume":"44","author":"H Ali Fadlalmola","year":"2023","unstructured":"Ali Fadlalmola H, Elhusein AM, Al-Sayaghi KM, Albadrani MS, Swamy DV, Mamanao DM, et al. Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. Pan Afr Med J. 2023;44:134. https:\/\/doi.org\/10.1160\/pamj.2023.44.134.32404.","journal-title":"Pan Afr Med J"},{"key":"1165_CR32","doi-asserted-by":"publisher","first-page":"2254848","DOI":"10.1080\/09513590.2023.2254848","volume":"39","author":"Y Ye","year":"2023","unstructured":"Ye Y, Zhou W, Ren Y, Lu J, Chen A, Jin R, et al. The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K\/AKT\/NF-kappaB and Nrf2\/HO-1 pathways. Gynecol Endocrinol. 2023;39:2254848. https:\/\/doi.org\/10.1080\/09513590.2023.2254848.","journal-title":"Gynecol Endocrinol"},{"key":"1165_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113821","volume":"270","author":"M Liu","year":"2021","unstructured":"Liu M, Zhu H, Zhu Y, Hu X. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K\/AKT\/mTOR signaling pathway. J Ethnopharmacol. 2021;270: 113821. https:\/\/doi.org\/10.1016\/j.jep.2021.113821.","journal-title":"J Ethnopharmacol"},{"key":"1165_CR34","doi-asserted-by":"publisher","first-page":"2210232","DOI":"10.1080\/09513590.2023.2210232","volume":"39","author":"P Wu","year":"2023","unstructured":"Wu P, Zhu Y, Li J, Chen H, Wu H, Hu X, et al. Guizhi Fuling Wan inhibits autophagy of granulosa cells in polycystic ovary syndrome mice via H19\/miR-29b-3p. Gynecol Endocrinol. 2023;39:2210232. https:\/\/doi.org\/10.1080\/09513590.2023.2210232.","journal-title":"Gynecol Endocrinol"},{"key":"1165_CR35","doi-asserted-by":"publisher","first-page":"2635375","DOI":"10.1155\/2022\/2635375","volume":"2022","author":"J Ding","year":"2022","unstructured":"Ding J, Shanshan M, Mengcheng C, Danying Z, Jin Y. Integrated network pharmacology and clinical study to reveal the effects and mechanisms of Bushen Huoxue Huatan decoction on polycystic ovary syndrome. Evid Based Complement Alternat Med. 2022;2022:2635375. https:\/\/doi.org\/10.1155\/2022\/2635375.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1165_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.525145","volume":"12","author":"Y Xu","year":"2021","unstructured":"Xu Y, Pan CS, Li Q, Zhang HL, Yan L, Anwaier G, et al. The ameliorating effects of Bushen Huatan Granules and Kunling wan on polycystic ovary syndrome induced by dehydroepiandrosterone in rats. Front Physiol. 2021;12: 525145. https:\/\/doi.org\/10.3389\/fphys.2021.525145.","journal-title":"Front Physiol"},{"key":"1165_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/196042a0","volume":"196","author":"S Roy","year":"1962","unstructured":"Roy S, Mahesh VB, Greenblatt RB. Effect of dehydroepiandrosterone and delta4-androstenedione on the reproductive organs of female rats: production of cystic changes in the ovary. Nature. 1962;196:42\u20133. https:\/\/doi.org\/10.1038\/196042a0.","journal-title":"Nature"},{"key":"1165_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.596525","volume":"11","author":"GL Bai","year":"2020","unstructured":"Bai GL, Hu KL, Huan Y, Wang X, Lei L, Zhang M, et al. The traditional chinese medicine fuyou formula alleviates precocious puberty by inhibiting GPR54\/GnRH in the hypothalamus. Front Pharmacol. 2020;11: 596525. https:\/\/doi.org\/10.3389\/fphar.2020.596525.","journal-title":"Front Pharmacol"},{"key":"1165_CR39","doi-asserted-by":"publisher","first-page":"2405098","DOI":"10.1080\/09513590.2024.2405098","volume":"40","author":"YX Jin","year":"2024","unstructured":"Jin YX, Hu HQ, Zhang JC, Xin XY, Zhu YT, Zhang HL, et al. Research status of polycystic ovary syndrome treatment: a mini review and a bibliometric analysis from 2010 to 2023. Gynecol Endocrinol. 2024;40:2405098. https:\/\/doi.org\/10.1080\/09513590.2024.2405098.","journal-title":"Gynecol Endocrinol"},{"key":"1165_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306991","volume":"19","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhu Y, Wang J, Hu H, Jin Y, Mao X, et al. Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: a systematic analysis from the Global Burden of Disease Study 2019. PLoS ONE. 2024;19: e0306991. https:\/\/doi.org\/10.1371\/journal.pone.0306991.","journal-title":"PLoS ONE"},{"key":"1165_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194128","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang H, Xin X, Zhu Y, Ye Y, Li D. Efficacy of flavonoids on animal models of polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14194128.","journal-title":"Nutrients"},{"key":"1165_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2022.100638","volume":"22","author":"H Chen","year":"2022","unstructured":"Chen H, Song L, Xu X, Han Z, Peng F, Zhang Q, et al. The effect of icariin on autoimmune premature ovarian insufficiency via modulation of Nrf2\/HO-1\/Sirt1 pathway in mice. Reprod Biol. 2022;22: 100638. https:\/\/doi.org\/10.1016\/j.repbio.2022.100638.","journal-title":"Reprod Biol"},{"key":"1165_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.104544","volume":"110","author":"N Zhang","year":"2020","unstructured":"Zhang N, Liu X, Zhuang L, Liu X, Zhao H, Shan Y, et al. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K\/AKT and MAPK pathways. Regul Toxicol Pharmacol. 2020;110: 104544. https:\/\/doi.org\/10.1016\/j.yrtph.2019.104544.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1165_CR44","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2147\/DMSO.S211188","volume":"12","author":"J Mi","year":"2019","unstructured":"Mi J, He W, Lv J, Zhuang K, Huang H, Quan S. Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats. Diabet Metab Syndr Obes. 2019;12:1717\u201325. https:\/\/doi.org\/10.2147\/DMSO.S211188.","journal-title":"Diabet Metab Syndr Obes"},{"key":"1165_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.31083\/j.fbl2906208","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Fang Y, Wang H, Zhang H. Balancing act: exploring the gut microbiota-brown adipose tissue axis in PCOS pathogenesis and therapeutic frontiers. Front Biosci. 2024;29:208. https:\/\/doi.org\/10.31083\/j.fbl2906208.","journal-title":"Front Biosci."},{"key":"1165_CR46","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1073\/pnas.1523236113","volume":"113","author":"X Yuan","year":"2016","unstructured":"Yuan X, Hu T, Zhao H, Huang Y, Ye R, Lin J, et al. Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Proc Natl Acad Sci U S A. 2016;113:2708\u201313. https:\/\/doi.org\/10.1073\/pnas.1523236113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1165_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jnutbio.2017.04.012","volume":"47","author":"T Hu","year":"2017","unstructured":"Hu T, Yuan X, Ye R, Zhou H, Lin J, Zhang C, et al. Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat. J Nutr Biochem. 2017;47:21\u20138. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.04.012.","journal-title":"J Nutr Biochem"},{"key":"1165_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713123","author":"KM Siemers","year":"2023","unstructured":"Siemers KM, Klein AK, Baack ML. Mitochondrial dysfunction in PCOS: insights into reproductive organ pathophysiology. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713123.","journal-title":"Int J Mol Sci."},{"key":"1165_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11154-023-09789-2","volume":"24","author":"P Shukla","year":"2023","unstructured":"Shukla P, Melkani GC. Mitochondrial epigenetic modifications and nuclear-mitochondrial communication: a new dimension towards understanding and attenuating the pathogenesis in women with PCOS. Rev Endocr Metab Disord. 2023;24:317\u201326. https:\/\/doi.org\/10.1007\/s11154-023-09789-2.","journal-title":"Rev Endocr Metab Disord"},{"key":"1165_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101583","volume":"65","author":"A Aflatounian","year":"2022","unstructured":"Aflatounian A, Paris VR, Richani D, Edwards MC, Cochran BJ, Ledger WL, et al. Declining muscle NAD(+) in a hyperandrogenism PCOS mouse model: possible role in metabolic dysregulation. Mol Metab. 2022;65: 101583. https:\/\/doi.org\/10.1016\/j.molmet.2022.101583.","journal-title":"Mol Metab"},{"key":"1165_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122769","author":"A Al-Shahat","year":"2022","unstructured":"Al-Shahat A, Hulail MAE, Soliman NMM, Khamis T, Fericean LM, Arisha AH, et al. Melatonin mitigates cisplatin-induced ovarian dysfunction via altering steroidogenesis, inflammation, apoptosis, oxidative stress, and PTEN\/PI3K\/Akt\/mTOR\/AMPK signaling pathway in female rats. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14122769.","journal-title":"Pharmaceutics"},{"key":"1165_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111113","volume":"521","author":"A Estienne","year":"2021","unstructured":"Estienne A, Bongrani A, Rame C, Kurowska P, Blaszczyk K, Rak A, et al. Energy sensors and reproductive hypothalamo-pituitary ovarian axis (HPO) in female mammals: Role of mTOR (mammalian target of rapamycin), AMPK (AMP-activated protein kinase) and SIRT1 (Sirtuin 1). Mol Cell Endocrinol. 2021;521: 111113. https:\/\/doi.org\/10.1016\/j.mce.2020.111113.","journal-title":"Mol Cell Endocrinol"},{"key":"1165_CR53","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.2147\/DDDT.S484531","volume":"18","author":"M Liu","year":"2024","unstructured":"Liu M, Guo S, Li X, Tian Y, Yu Y, Tang L, et al. Semaglutide alleviates ovary inflammation via the AMPK\/SIRT1\/NF-kappaB signaling pathway in polycystic ovary syndrome mice. Drug Des Devel Ther. 2024;18:3925\u201338. https:\/\/doi.org\/10.2147\/DDDT.S484531.","journal-title":"Drug Des Devel Ther"},{"key":"1165_CR54","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1038\/s41467-023-38401-z","volume":"14","author":"JM Park","year":"2023","unstructured":"Park JM, Lee DH, Kim DH. Redefining the role of AMPK in autophagy and the energy stress response. Nat Commun. 2023;14:2994. https:\/\/doi.org\/10.1038\/s41467-023-38401-z.","journal-title":"Nat Commun"},{"key":"1165_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg GR, Hardie DG. New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol. 2023;24:255\u201372. https:\/\/doi.org\/10.1038\/s41580-022-00547-x.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1165_CR56","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1210\/endrev\/bnad012","volume":"44","author":"LK Townsend","year":"2023","unstructured":"Townsend LK, Steinberg GR. AMPK and the endocrine control of metabolism. Endocr Rev. 2023;44:910\u201333. https:\/\/doi.org\/10.1210\/endrev\/bnad012.","journal-title":"Endocr Rev"},{"key":"1165_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156353","volume":"137","author":"SH Kim","year":"2025","unstructured":"Kim SH, Park WY, Song G, Park JY, Jung SJ, Ahn KS, et al. 4-hydroxybenzoic acid induces browning of white adipose tissue through the AMPK-DRP1 pathway in HFD-induced obese mice. Phytomedicine. 2025;137: 156353. https:\/\/doi.org\/10.1016\/j.phymed.2024.156353.","journal-title":"Phytomedicine"},{"key":"1165_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13024","volume":"18","author":"LJ Chen","year":"2019","unstructured":"Chen LJ, Yang ZX, Wang Y, Du L, Li YR, Zhang NN, et al. Single xenotransplant of rat brown adipose tissue prolonged the ovarian lifespan of aging mice by improving follicle survival. Aging Cell. 2019;18: e13024. https:\/\/doi.org\/10.1111\/acel.13024.","journal-title":"Aging Cell"},{"key":"1165_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13643-019-0962-3","volume":"8","author":"C Kite","year":"2019","unstructured":"Kite C, Lahart IM, Afzal I, Broom DR, Randeva H, Kyrou I, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis. Syst Rev. 2019;8:51. https:\/\/doi.org\/10.1186\/s13643-019-0962-3.","journal-title":"Syst Rev"},{"key":"1165_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12958-017-0313-y","volume":"15","author":"SF de Medeiros","year":"2017","unstructured":"de Medeiros SF. Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome. Reprod Biol Endocrinol. 2017;15:93. https:\/\/doi.org\/10.1186\/s12958-017-0313-y.","journal-title":"Reprod Biol Endocrinol"},{"key":"1165_CR61","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.12659\/MSM.910743","volume":"24","author":"Y Chen","year":"2018","unstructured":"Chen Y, Yang T, Hao C, Zhao J. A retrospective study of letrozole treatment prior to human chorionic gonadotropin in women with polycystic ovary syndrome undergoing in vitro fertilization at risk of ovarian hyperstimulation syndrome. Med Sci Monit. 2018;24:4248\u201353. https:\/\/doi.org\/10.12659\/MSM.910743.","journal-title":"Med Sci Monit"},{"key":"1165_CR62","doi-asserted-by":"publisher","first-page":"725","DOI":"10.25122\/jml-2023-0069","volume":"16","author":"S Al-Thuwaynee","year":"2023","unstructured":"Al-Thuwaynee S, Swadi AAJ. Comparing efficacy and safety of stair step protocols for clomiphene citrate and letrozole in ovulation induction for women with polycystic ovary syndrome (PCOS): a randomized controlled clinical trial. J Med Life. 2023;16:725\u201330. https:\/\/doi.org\/10.25122\/jml-2023-0069.","journal-title":"J Med Life"},{"key":"1165_CR63","doi-asserted-by":"publisher","first-page":"4086864","DOI":"10.1155\/2020\/4086864","volume":"2020","author":"W Xu","year":"2020","unstructured":"Xu W, Tang M, Wang J, Wang L. Identification of the active constituents and significant pathways of Cangfu Daotan decoction for the treatment of PCOS based on network pharmacology. Evid Based Complement Alternat Med. 2020;2020:4086864. https:\/\/doi.org\/10.1155\/2020\/4086864.","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01165-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01165-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01165-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:18:26Z","timestamp":1751368706000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01165-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01165-3","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment protocol complied with the Guide for the Care and Use of Laboratory Animals and was approval by the Animal Care and Use Committee of Peking University (LA2016314).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agree to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}